1620579-56-7

Basic information

• Product Name: 3-fluoro-4-((5-(trifluoromethyl)pyridin-3-yl)oxy)benzaldehyde
• Synonyms: 3-fluoro-4-((5-(trifluoromethyl)pyridin-3-yl)oxy)benzaldehyde
• CAS NO: 1620579-56-7
• Molecular Weight: 285.198
• Mol File: 1620579-56-7.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3-fluoro-4-((5-(trifluoromethyl)pyridin-3-yl)oxy)benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 3-fluoro-4-((5-(trifluoromethyl)pyridin-3-yl)oxy)benzaldehyde(1620579-56-7)
• EPA Substance Registry System: 3-fluoro-4-((5-(trifluoromethyl)pyridin-3-yl)oxy)benzaldehyde(1620579-56-7)

Safety Data

• Hazardous Substances Data: 1620579-56-7(Hazardous Substances Data)

Upstream product

• 85148-26-1 3-chloro-5-(trifluoromethyl)pyridine 
• 34036-07-2 3,4 difluorobenzaldehyde 
• 186593-14-6 5-(trifluoromethyl)pyridin-3-ol 

Downstream Products

• 1421434-98-1 (3-fluoro-4-((5-(trifluoromethyl)pyridin-3-yl)oxy)phenyl)methanol 

Relevant articles and documents

COMPOUNDS

The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example Alzheimer's disease.

BICYCLIC PYRIMIDONE COMPOUNDS AS INHIBITORS OF LP-PLA2

The present invention relates to novel pyrimido[1,6-a]pyrimidin-6(2H)-one compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.